Return to content in this issue

Compassionate Use of Reslizumab in a Life-Threatening Asthma Exacerbation

Granda P¹, Villamañán E^2,3, Heinz S¹, Laorden D⁴, Romero D⁴, Añón JM⁵, Carpio C^3,4, Sobrino C², Collada V², Domínguez-Ortega J⁶, Herrero A², Quirce S⁶, Álvarez-Sala R<sup>3,4

1</sup>Pharmacy Department, Hospital Central de la Defensa Gómez-Ulla, Madrid, Spain
²Pharmacy Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
³Medicine Department, Universidad Autónoma de Madrid, Spain
⁴Pneumology Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
⁵Intensive Care Unit, Hospital Universitario La Paz. IdiPAZ, CIBERES, Instituto de Salud Carlos III, Madrid, Spain
⁶Allergy Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain

J Investig Allergol Clin Immunol 2024; Vol. 34(1)
doi: 10.18176/jiaci.0920

• Abstract
• Supplemental Materials

Key words: Severe asthma, Critical care, Reslizumab

	Title	Type	Size
	doi10.18176_jiaci.0920_supplemental-materials-table.pdf	pdf	100.67 Kb